Vitamin D Supplementation in Covid-19: A Friend or Foe?

Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share this content! On (X network) By

Vitamin D Supplementation in Covid-19: A Friend or Foe? Publisher

Mansour A¹ ; Mohajeritehrani MR¹ ; Sajjadijazi SM^{1, 2}

Show Affiliations

1. Endocrinology and Metabolism Research Institute (EMRI), Tehran University of Medical Sciences, Tehran, Iran
2. Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: EXCLI Journal Published:2020

Abstract

[No abstract available]

Related Docs

View other Related Docs

1. The Association Between Baseline Vitamin D Level and Clinical Outcomes in Patients With Covid-19 a 7-Month Follow-Up Cohort Study, Topics in Clinical Nutrition (2024)

2. Association of Vitamin D Receptor Gene Polymorphisms and Clinical/Severe Outcomes of Covid-19 Patients, Infection# Genetics and Evolution (2021)

3. Molecular Mechanisms and Therapeutic Effects of Different Vitamins and Minerals in Covid-19 Patients, Journal of Trace Elements in Medicine and Biology (2022)

4. The Evaluation of Clinical Symptoms and Underlying Factors in Infected Patients With Covid-19, Tehran University Medical Journal (2021)

5. Dietary Patterns and Micronutrients in Respiratory Infections Including Covid-19: A Narrative Review, BMC Public Health (2024)

6. Association of Recent and Long-Term Supplement Intakes With Laboratory Indices in Patients With Covid-19 in Tehran, Iran, During 2020, Frontiers in Nutrition (2022)

7. Role of Vitamin D in Pathogenesis and Severity of Covid-19 Infection, Archives of Physiology and Biochemistry (2023)

8. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)

Experts (# of related papers)

View all Related Experts

Azar Hadadi (2)

Hedieh Moradi Tabriz (2)

Other Related Docs

9. Nutritional Approach for Increasing Public Health During Pandemic of Covid-19: A Comprehensive Review of Antiviral Nutrients and Nutraceuticals, Health Promotion Perspectives (2021)

10. Vitamin D Sufficiency, a Serum 25-Hydroxyvitamin D at Least 30 Ng/Ml Reduced Risk for Adverse Clinical Outcomes in Patients With Covid-19 Infection, PLoS ONE (2020)

Style	Citing Format
MLA	Mansour A, Mohajeritehrani MR, Sajjadijazi SM. "Vitamin D Supplementation in Covid-19: A Friend or Foe?." EXCLI Journal, vol. 19, no. , 2020, pp. 1166-1168.
APA	Mansour A, Mohajeritehrani MR, Sajjadijazi SM (2020). Vitamin D Supplementation in Covid-19: A Friend or Foe?. EXCLI Journal, 19(), 1166-1168.
Chicago	Mansour A, Mohajeritehrani MR, Sajjadijazi SM. "Vitamin D Supplementation in Covid-19: A Friend or Foe?." EXCLI Journal 19, no. (2020): 1166-1168.
Harvard	Mansour A, Mohajeritehrani MR, Sajjadijazi SM (2020) 'Vitamin D Supplementation in Covid-19: A Friend or Foe?', EXCLI Journal, 19(), pp. 1166-1168.
Vancouver	Mansour A, Mohajeritehrani MR, Sajjadijazi SM. Vitamin D Supplementation in Covid-19: A Friend or Foe?. EXCLI Journal. 2020;19():1166-1168.
BibTex	@article{ author = {Mansour A and Mohajeritehrani MR and Sajjadijazi SM}, title = {Vitamin D Supplementation in Covid-19: A Friend or Foe?}, journal = {EXCLI Journal}, volume = {19}, number = {}, pages = {1166-1168}, year = {2020} }
RIS	TY - JOUR AU - Mansour A AU - Mohajeritehrani MR AU - Sajjadijazi SM TI - Vitamin D Supplementation in Covid-19: A Friend or Foe? JO - EXCLI Journal VL - 19 IS - SP - 1166 EP - 1168 PY - 2020 ER -